ALK's Partner, Torii Pharmaceutical, Reports Positive Phase II/III Trial Results for Japanese Cedar SLIT-tablet

ALK (OTC: AKBLF) today announced that its partner for Japan, Torii Pharmaceutical Co., Ltd. , has reported positive results from its ...